Analysis of Therapeutic Management Strategies for Anal Suppurations of Crohn's Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRennes University Hospital
About this trial
Determine the optimal therapeutic combination associated with complete clinical and anatomical remission of anal suppurations of Crohn's disease at 12 months.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Persons over 18 years of age
People suffering from anal suppuration of Crohn's disease for whom a drainage procedure is planned.
Person who has received written and oral information about the protocol and has not expressed opposition to participate in the study.
Disqualifiers
No one who is unable to have an anesthetic, structural or psychological examination by MRI and/or surgery.
Person planning a planned absence that could hinder participation in the research (travel abroad, relocation, impending transfer);
Person with an associated pathology that is a priority for care;
Vulnerable person (minors, persons under guardianship or curatorship, or deprived of their liberty by a judicial or administrative decision
Trial population
Person suffering from anal suppuration related to Crohn's Disease
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
surgical treatment
Procedure/Surgerysurgical drainage and/or surgical reconstruction procedures to anoperineal suppurations according to the doctor's decision
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Clinical and anatomical healing
The healing of anal fistula is defined by the combination of two criteria at 12 months : * MRI criteria = absence of a T2 hyper signal from the path(s) AND the absence of an abscess AND * Complete clinical response = no pain, no discharge, and no drain
Time frame
12 months.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov